Skip to main content

People in the News: Feb 23, 2010


Stephen Lombardi has left his job as president of Helicos BioSciences, and current CEO Ronald Lowy will take over the position, the company said in a recent filing with the US Securities and Exchange Commission.

Lombardi, who also has resigned from the firm's board of directors, will receive the amount of his gross annual salary of $375,000 in severance, plus stock options. Prior to joining Helicos, Lombardi had served as senior vice president at Affymetrix. Lowy has been CEO of Helicos since late 2007, and before that he was CEO and president of Fisher Biosciences, part of Thermo Fisher Scientific.

The Human Genome Organization has re-elected its president Edison Liu. Liu is executive director of the Genome Institute of Singapore and he has been HUGO's president since 2007.

Martin Schneider is now chair of the advisory board of imaGenes, the Berlin-based genomics services company said last week. Schneider replaces Klaus Schmidt-Menschner, who left to pursue other interests. Schneider is head of global therapeutic research at Bayer Schering Pharma. He was previously head of global target discovery and biomarkers at Bayer. Before that, he was head of enabling technologies at Schering.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.